title: Prostacyclin but not phentolamine increases oxygen consumption and skin microvascular blood flow in patients with sepsis and respiratory failure.
abstract: Inadequate tissue oxygenation may occur in critically ill patients with sepsis despite an apparently adequate O2 transport (QO2), and this may contribute to the development of an O2 debt and also to multiple organ failure. It has been shown that increasing QO2 by infusing a vasodilator may reveal this O2 debt in septic patients. To investigate whether the site of action of vasodilators may be of importance in unmasking such an O2 debt, we administered prostacyclin, a prostaglandin with a preferential effect on the microcirculation, and phentolamine, an arteriolar vasodilator, in 11 patients studied during the first 48 hours after the onset of sepsis, and compared their effect on whole body oxygen consumption (VO2) and skin microvascular blood flow. The results demonstrated that increasing QO2 by prostacyclin but not by phentolamine significantly increases VO2 in critically ill patients with sepsis. The site of action of vasodilators may therefore play an important role in their ability to unmask an O2 debt.
authors: Department of Anesthesiology, University Hospital, Geneva, Switzerland.
authors: J F
authors: JF
authors: Pittet
authors: J S
authors: JS
authors: Lacroix
authors: K
authors: K
authors: Gunning
authors: M C
authors: MC
authors: Laverriere
authors: D R
authors: DR
authors: Morel
authors: P M
authors: PM
authors: Suter
mesh_terms: D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000150:complications* / Q000503:physiopathology; D011464:Epoprostenol / Q000494:pharmacology*; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000503:physiopathology; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects*; D010646:Phentolamine / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D012131:Respiratory Insufficiency / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D012867:Skin / Q000098:blood supply* / Q000378:metabolism
chemical_list: D011464:Epoprostenol; D010100:Oxygen; D010646:Phentolamine